Protein phosphorylation in anaplastic large cell lymphoma
Abstract
A method for detecting or quantifying a signaling protein that is tyrosine phosphorylated in signaling pathways receptor T cells, said method comprising the step of using one or more of the following reagents to detect or quantify the signaling protein T cell receptors Cdk 6 only when phosphorylated at the tyrosine 13 or 24: (i) a specific antibody isolated phosphorylation site that specifically binds said protein only when phosphorylated at the tyrosine 13 or 24 comprised in the sequence phosphorylation site SEQ ID nO: 60 or SEQ ID nO: 61, wherein said antibody does not bind said protein when not phosphorylated at said tyrosine; 60 or SEQ ID NO: 61, comprising tyrosine and / or (ii) a peptide labeled with a heavy isotope (AQUA peptide) for the quantification of said protein, said labeled peptide sequence phosphorylation site SEQ ID NO comprising phosphorylated 13 or 24.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
90 members in 9 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 77789304 | United States of America | A |
Members90
| Document | Office | Kind | |
|---|---|---|---|
| CA2341143A1 | Canada | A1 | |
| WO0014536A1 | World Intellectual Property Organization (WIPO) | A1 | |
| EP1110086A1 | European Patent Office (EPO) | A1 | |
| JP2002524092A | Japan | A | |
| US6441140B1 | United States of America | B1 | |
| US2002132988A1 | United States of America | A1 | |
| US2002168684A1 | United States of America | A1 | |
| CA2454605A1 | Canada | A1 | |
| WO03000931A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US2003044848A1 | United States of America | A1 | |
| US2003068652A1 | United States of America | A1 | |
| EP1110086A4 | European Patent Office (EPO) | A4 | |
| WO03107003A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2002310452A1 | Australia | A1 | |
| EP1434874A1 | European Patent Office (EPO) | A1 | |
| DE02747916T1 | Germany | T1 | |
| US2005003450A1 | United States of America | A1 | |
| JP2005225858A | Japan | A | |
| CA2556019A1 | Canada | A1 | |
| CA2556021A1 | Canada | A1 | |
| CA2556022A1 | Canada | A1 | |
| WO2005083113A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO2005083439A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO2005083444A1 | World Intellectual Property Organization (WIPO) | A1 | |
| EP1434874A4 | European Patent Office (EPO) | A4 | |
| US6982318B1 | United States of America | B1 | |
| JP3732408B2 | Japan | B2 | |
| JP2006036784A | Japan | A | |
| AU2002318361B2 | Australia | B2 | |
| AU2006203222A1 | Australia | A1 | |
| CA2454605C | Canada | C | |
| EP1718760A1 | European Patent Office (EPO) | A1 | |
| EP1718976A1 | European Patent Office (EPO) | A1 | |
| EP1718977A1 | European Patent Office (EPO) | A1 | |
| CA2341143C | Canada | C | |
| US2007026461A1 | United States of America | A1 | |
| US2007059845A1 | United States of America | A1 | |
| US2007072235A1 | United States of America | A1 | |
| US7198896B2 | United States of America | B2 | |
| EP1110086B1 | European Patent Office (EPO) | B1 | |
| DE69936389D1 | Germany | D1 | |
| US7259022B2 | United States of America | B2 | |
| EP1850131A1 | European Patent Office (EPO) | A1 | |
| US7300753B2 | United States of America | B2 | |
| JP2007308506A | Japan | A | |
| DE69936389T2 | Germany | T2 | |
| US7344714B2 | United States of America | B2 | |
| EP1718976B1 | European Patent Office (EPO) | B1 | |
| EP1718977B1 | European Patent Office (EPO) | B1 | |
| AT417273TThis record | Austria | T | |
| AT417276T | Austria | T | |
| ATE417273T1 | Austria | T1 | |
| ATE417276T1 | Austria | T1 | |
| EP1718760B1 | European Patent Office (EPO) | B1 | |
| AT419379T | Austria | T | |
| ATE419379T1 | Austria | T1 | |
| DE602004018388D1 | Germany | D1 | |
| DE602004018390D1 | Germany | D1 | |
| DE602004018836D1 | Germany | D1 | |
| ES2317044T3 | Spain | T3 | |
| ES2321197T3 | Spain | T3 | |
| ES2321520T3 | Spain | T3 | |
| US2011053242A1 | United States of America | A1 | |
| US7935790B2 | United States of America | B2 | |
| US2011111424A1 | United States of America | A1 | |
| EP2325204A2 | European Patent Office (EPO) | A2 | |
| EP2339027A2 | European Patent Office (EPO) | A2 | |
| US7973134B2 | United States of America | B2 | |
| EP2325204A3 | European Patent Office (EPO) | A3 | |
| EP2339027A3 | European Patent Office (EPO) | A3 | |
| JP5013693B2 | Japan | B2 | |
| JP2012162535A | Japan | A | |
| US2012244594A9 | United States of America | A9 | |
| EP1850131B1 | European Patent Office (EPO) | B1 | |
| US2013245237A1 | United States of America | A1 | |
| US2014094594A1 | United States of America | A1 | |
| JP2014132019A | Japan | A | |
| EP2325204B1 | European Patent Office (EPO) | B1 | |
| JP5648007B2 | Japan | B2 | |
| US9085609B2 | United States of America | B2 | |
| US2015232540A1 | United States of America | A1 | |
| US2015259405A1 | United States of America | A1 | |
| US9181326B2 | United States of America | B2 | |
| JP2016210783A | Japan | A | |
| US9587013B2 | United States of America | B2 | |
| US9738711B2 | United States of America | B2 | |
| US2018009884A1 | United States of America | A1 | |
| EP3467122A1 | European Patent Office (EPO) | A1 | |
| US2020131254A1 | United States of America | A1 | |
| US11352418B2 | United States of America | B2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 4777654
Titles2
- German
- PROTEINPHOSPHORYLIERUNG BEI GROSSZELLIG- ANAPLASTISCHEM LYMPHOM
- English
- PROTEIN PHOSPHORYLING IN BULK CELL ANAPLASTIC LYMPHOMA
Classification
- CPC, 6
- G01N33/6872
- C07K14/47
- C07K16/44
- C12Q1/25
- C12Q1/485
- G01N33/6842
- IPC, 11
- C07K1 22
- C07K14 47
- C07K16 00
- C07K16 18
- C07K16 44
- C12P21 06
- C12P21 08
- C12Q1 25
- C12Q1 48
- G01N33 574
- G01N33 68